DOCSLIB.ORG

Characterizing the Mechanisms of Kappa Opioid Receptor Signaling Within Mesolimbic Dopamine Circuitry Katie Reichard a Dissertat

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Characterizing the Mechanisms of Kappa Opioid Receptor Signaling Within Mesolimbic Dopamine Circuitry Katie Reichard a Dissertat Characterizing the mechanisms of kappa opioid receptor signaling within mesolimbic dopamine circuitry Katie Reichard A dissertation submitted in partial fulfillment of the degree requirements for the degree of: Doctor of Philosophy University of Washington 2020 Reading Committee: Charles Chavkin, Chair Paul Phillips Larry Zweifel Program Authorized to Confer Degree: Neuroscience Graduate Program TABLE OF CONTENTS Summary/Abstract………………………………………………………………………….……..6 Dedication……………………………………………………………………………….………...9 Chapter 1 The therapeutic potential of the targeting the kappa opioid receptor system in stress- associated mental health disorders……………………………….………………………………10 Section 1.1 Activation of the dynorphin/kappa opioid receptor system is associated with dysphoria, cognitive disruption, and increased preference for drugs of abuse…………………..13 Section 1.2 Contribution of the dyn/KOR system to substance use disorder, anxiety, and depression………………………………………………………………………………………..15 Section 1.3 KORs are expressed on dorsal raphe serotonin neurons and contribute to stress- induced plasticity with serotonin circuitry……………………………………………………….17 Section 1.4 Kappa opioid receptor expression in the VTA contributes to the behavioral response to stress……………………………………………………………………………………....…..19 Section 1.5 Other brain regions contributing to the KOR-mediated response to stress…………23 Section 1.6 G Protein signaling at the KOR …………………………………………………….25 Chapter 2: JNK-Receptor Inactivation Affects D2 Receptor through both agonist action and norBNI-mediated cross-inactivation Introduction………………………………………………………………………………………32 Methods…………………………………………………………………………………..………34 Results……………………………………………………………………………………………35 Discussion………………………………………………………………………………………..40 Chapter 3: Dopamine neurons of the VTA are heterogenous and there is a sex difference in their responses to KOR agonists 2 Introduction………………………………………………………………………………………43 Methods………………………………………………………………………………………......46 Results……………………………………………………………………………………………47 Discussion ……………………………………………………………………………………….52 Chapter 4: Regulation of kappa opioid receptor inactivation depends on sex and cellular site of antagonist action Introduction………………………………………………………………………………………56 Methods……………………………………………………………….………………………….58 Results...…………………………………………………………….……………………………63 Discussion…………………………………………….………………………………………….75 Chapter 5: Evaluating the Contribution of Pre- and Postsynaptic Potassium Channels to KOR Regulation of Dopamine Neurons Introduction ……………………………………………………………………………………..80 Methods …………………………………………………………………………………………83 Results.…………………………………………… …………………………………………….86 Discussion ………………………………………………………………………………………94 Thesis Summary and Conclusions…………………….……………………………………….106 Curriculum Vitae……………………………………………………………………………….107 Bibliography………………………….………………………………………………………...110 3 LIST OF FIGURES # Title Page # 2.1 NorBNI pretreatment shifts potency of quinpirole at inhibition of dopamine 37 release 2.2 D2 Receptor stimulation by quinpirole results in MJ33-dependent ROS 39 production in HEK293 cells expression both the short and long isoform of DRD2 3.1 Characterization of optically evoked dopamine release from subpopulations 50 of dopamine neurons genetically defined by neuropeptide genes 3.2 Sex Differences in U69,593 inhibition of dopamine release 52 4.1 Long-acting norBNI antagonism in females is effective if given in repeated 69 doses or after CMPD101 4.2 norBNI does not cause a long-lasting block of KOR inhibition of dopamine 71 release in the nucleus accumbens (NAc) core, whereas b-CNA receptor inactivation persists at least a week in NAc terminals 4.3 KOR Agonist U69,593 Activates a GIRK current in VTA dopamine neurons 73 that can be blocked by norBNI pretreatment 4.4 KOR agonist, nalfurafine, generates reactive oxygen species in VTA 74 Dopamine cell bodies, but not dopamine terminals in the nucleus accumbens, as measured by HyPerRed. 5.1 Non-specific potassium channel blockers attenuate the inhibition of dopamine 97 release by KOR agonist U69,593 5.2 Selective knockdown of potassium channels in dopamine neurons using 99 AAV-FLEX-SaCas9-U6-SgRNA. 5.3 Assessment of the KCNA2 knockdown on the regulation of evoked dopamine 101 release and dopamine-mediated behaviors 5.4 Genetic and functional validation of AAV1-FLEX-SaCas9-sgRNA(Kcnj6) 102 5.5 Impact of KCNJ6 knockdown on KOR signaling and U50,488 Conditioned 104 Place Aversion 4 Abstract & Public Summary An essay is due, your rent check is late, the national guard has been deployed to your city, you are experiencing violence within your own home: humans experience stress in varying degrees and durations throughout their lives, and the severity and proportionality often align with societal inequities. As stress neurobiologists, we play a role in describing the ways this stress manifests in our bodies, how it forever alters the pathways in our brains and shifts our own reactions to the world around us. In part, we do this work to understand the basic science of stress and how it increases risk for diseases like heart disease, stroke, hypertension, anxiety, depression, and substance use disorders. We also seek to find treatments, so that while society inflicts unearned stressors on its most vulnerable citizens, we may use pharmacology to ameliorate a fraction of its harms. Our bodies use neuropeptides to modulate our behavioral and emotional responding to stimuli, like stress. These small proteins act on receptors in our brain cells, or neurons, to promote certain behaviors and make long-lasting changes in neural connectivity. The opioid peptide dynorphin is produced in multiple brain regions, including those involved in decision making and reward learning, and plays an important role in the stress response. When released in response to drug-taking or stress, dynorphin (dyn) binds to a receptor called the kappa opioid receptor (KOR). Years of research from the Chavkin lab and others have shown that signaling at the kappa opioid receptor contributes to increased depression, anxiety, and substance use after the experience of behavioral stress. Researchers have also shown that molecules which can block dynorphin from binding to its receptor can reduce these negative psychological consequences. This dissertation digs into two big questions surrounding the effects of kappa opioid receptors: (1) How do the antagonists, or compounds which disrupt KOR signaling, work and how does 5 this knowledge help us better design therapeutic compounds in the future and (2) How do KORs signal within dopamine neurons, a population of neurons involved in decision making & reward that is altered by stress. In Chapter 1, I review the literature evaluating the therapeutic potential for KOR antagonists in treating mood disorders and substance use disorders. The chapter describes studies that demonstrated the role of dyn/KOR in mood and substance use disorders, reviews the brain regions critical for these behaviors, and discusses the importance of biased agonism and development of functionally selective ligands. In Chapter 2, I assess the role of c-Jun Kinase (JNK) signaling both by KOR antagonist norbinaltorphimine (norBNI) and Dopamine D2 Receptor agonist quinpirole. Both agonists and antagonists of the KOR can stimulate JNK signaling, producing reactive oxygen species and disrupting signaling. We found that Quinpirole can stimulate JNK-dependent ROS at both D2 receptor isoforms. We also found that NorBNI pretreatment shifts the dose response to Quinpirole at inhibiting dopamine release, indicating that JNK-ROS stimulated by the KOR can disrupt signaling at neighboring Gi-coupled receptors. In Chapter 3, I present findings from two collaborations assessing the regulation of presynaptic dopamine release in the nucleus accumbens. We found that KOR-mediated inhibition of dopamine release is less potent in female mice, and that this effect is blocked by the GRK inhibitor CMPD101. In a collaboration with the Zweifel lab, I also helped demonstrate that different neuropeptide marker genes, CCK and CRHR1, segregate populations of dopamine 6 neurons which project to the NAc Shell and NAc Core, respectively. In Chapter 4, I present findings which discuss the mechanism and limitations of KOR antagonist norBNI. We found that there are sex-differences in the long-lasting nature of norBNI, which are prevented by pretreatment with GRK inhibitor CMPD101. We also found that norBNI is not long-lasting at dopamine terminals, an effect that may be due to the lack of ROS production downstream of norBNI in NAc terminals. In Chapter 5, results from a series of experiments assessing the role of potassium channels in the kappa opioid receptor regulation of dopamine neurons. We used a CRISPR-Cas9 based system to knockdown genes for KV1.2, KV3.4, and Kir3.2 or GIRK2 (KCNA2, KCNC4, KCNJ6). We then assess the effect of those knockdowns on basal dopamine physiology and KOR signaling in dopamine neurons. 7 Dedication I dedicate this work, with gratitude & love, to my family: Mat, Jess, Sandell, Steve, and Fika. This dissertation was written in the midst of the 2020 COVID-19 Pandemic. I also dedicate this work to the first responders, essential workers, medical professionals, basic scientists, virologists, epidemiologists, and vaccinologists fighting for humanity. To the souls we’ve lost and their families and those still battling this virus. 8 Chapter 1 The therapeutic potential of the targeting the kappa opioid receptor system in stress-associated mental health disorders Introduction The stress response
Load more

Recommended publications
  • RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate
    Published OnlineFirst June 13, 2017; DOI: 10.1158/0008-5472.CAN-17-0669 Cancer Molecular and Cellular Pathobiology Research RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression Yongquan Wang1,2, Jianghua Wang2, Li Zhang2,3, Omer Faruk Karatas2, Longjiang Shao2, Yiqun Zhang4, Patricia Castro2, Chad J. Creighton4,5,and Michael Ittmann2 Abstract African American (AA) men exhibit a relatively high incidence epithelial cells. Notably, RGS12 exhibited potent tumor-suppres- and mortality due to prostate cancer even after adjustment for sor activity in prostate cancer and prostate epithelial cell lines in socioeconomic factors, but the biological basis for this disparity is vitro and in vivo. We found that RGS12 expression correlated unclear. Here, we identify a novel region on chromosome 4p16.3 negatively with the oncogene MNX1 and regulated its expression that is lost selectively in AA prostate cancer. The negative regulator in vitro and in vivo. Further, MNX1 was regulated by AKT activity, of G-protein signaling RGS12 was defined as the target of 4p16.3 and RGS12 expression decreased total and activated AKT levels. deletions, although it has not been implicated previously as a Our findings identify RGS12 as a candidate tumor-suppressor tumor-suppressor gene. RGS12 transcript levels were relatively gene in AA prostate cancer, which acts by decreasing expression of reduced in AA prostate cancer, and prostate cancer cell lines AKT and MNX1, establishing a novel oncogenic axis in this showed decreased RGS12 expression relative to benign prostate disparate disease setting. Cancer Res; 77(16); 1–11.
    [Show full text]
  • The Mineralocorticoid Receptor Leads to Increased Expression of EGFR
    www.nature.com/scientificreports OPEN The mineralocorticoid receptor leads to increased expression of EGFR and T‑type calcium channels that support HL‑1 cell hypertrophy Katharina Stroedecke1,2, Sandra Meinel1,2, Fritz Markwardt1, Udo Kloeckner1, Nicole Straetz1, Katja Quarch1, Barbara Schreier1, Michael Kopf1, Michael Gekle1 & Claudia Grossmann1* The EGF receptor (EGFR) has been extensively studied in tumor biology and recently a role in cardiovascular pathophysiology was suggested. The mineralocorticoid receptor (MR) is an important efector of the renin–angiotensin–aldosterone‑system and elicits pathophysiological efects in the cardiovascular system; however, the underlying molecular mechanisms are unclear. Our aim was to investigate the importance of EGFR for MR‑mediated cardiovascular pathophysiology because MR is known to induce EGFR expression. We identifed a SNP within the EGFR promoter that modulates MR‑induced EGFR expression. In RNA‑sequencing and qPCR experiments in heart tissue of EGFR KO and WT mice, changes in EGFR abundance led to diferential expression of cardiac ion channels, especially of the T‑type calcium channel CACNA1H. Accordingly, CACNA1H expression was increased in WT mice after in vivo MR activation by aldosterone but not in respective EGFR KO mice. Aldosterone‑ and EGF‑responsiveness of CACNA1H expression was confrmed in HL‑1 cells by Western blot and by measuring peak current density of T‑type calcium channels. Aldosterone‑induced CACNA1H protein expression could be abrogated by the EGFR inhibitor AG1478. Furthermore, inhibition of T‑type calcium channels with mibefradil or ML218 reduced diameter, volume and BNP levels in HL‑1 cells. In conclusion the MR regulates EGFR and CACNA1H expression, which has an efect on HL‑1 cell diameter, and the extent of this regulation seems to depend on the SNP‑216 (G/T) genotype.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Metabotropic Glutamate Receptor Mglur1 Regulates the Voltage-Gated Potassium Channel Kv1.2 Through Agonist-Dependent and Agonist-Independent Mechanisms
    University of Vermont ScholarWorks @ UVM Graduate College Dissertations and Theses Dissertations and Theses 2019 The etM abotropic glutamate receptor mGluR1 regulates the voltage-gated potassium channel Kv1.2 through agonist-dependent and agonist- independent mechanisms Sharath Chandra Madasu University of Vermont Follow this and additional works at: https://scholarworks.uvm.edu/graddis Part of the Cell Biology Commons, Neuroscience and Neurobiology Commons, and the Pharmacology Commons Recommended Citation Madasu, Sharath Chandra, "The eM tabotropic glutamate receptor mGluR1 regulates the voltage-gated potassium channel Kv1.2 through agonist-dependent and agonist-independent mechanisms" (2019). Graduate College Dissertations and Theses. 982. https://scholarworks.uvm.edu/graddis/982 This Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks @ UVM. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact [email protected]. THE METABOTROPIC GLUTAMATE RECEPTOR MGLUR1 REGULATES THE VOLTAGE-GATED POTASSIUM CHANNEL KV1.2 THROUGH AGONIST-DEPENDENT AND AGONIST-INDEPENDENT MECHANISMS. A Dissertation Presented by Sharath Chandra Madasu to The Faculty of the Graduate College of The University of Vermont In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Specializing in Cellular Molecular and Biomedical Science January, 2019 Defense Date: September 27, 2018 Dissertation Examination Committee: Anthony D. Morielli, PhD., Advisor John Green, PhD., Chairperson Karen Lounsbury, Ph.D. Benedek Erdos, PhD. Cynthia J. Forehand, Ph.D., Dean of the Graduate College ABSTRACT The voltage gated potassium channel Kv1.2 plays a key role in the central nervous system and mutations in Kv1.2 cause neurological disorders such as epilepsies and ataxias.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Mx1cre Mediated Rgs12 Conditional Knockout Mice Exhibit Increased
    VC 2013 Wiley Periodicals, Inc. genesis 51:201–209 (2013) TECHNOLOGY REPORT Mx1-Cre Mediated Rgs12 Conditional Knockout Mice Exhibit Increased Bone Mass Phenotype Shuying Yang,1,2* Yi-Ping Li,3 Tongjun Liu,1,4 Xiaoning He,1,5 Xue Yuan,1 Chunyi Li,1 Jay Cao,6 and Yunjung Kim1 1Department of Oral Biology, School of Dental Medicine, University of Buffalo, State University of New York, Buffalo, New York 2Developmental Genomics Group, New York State Center of Excellence in Bioinformatics and Life Sciences, University of Buffalo, The State University of New York, Buffalo, New York 3Department of Pathology, University of Alabama at Birmingham (UAB), Birmingham, Alabama 4Department of Stomatology, Jinan Central Hospital, Shandong University, Jinan, 250013 People’s Republic of China 5Department of Stomatology, The 4th Affiliated Hospital of China Medical University, China Medical University, Shenyang, Liaoning, 110032, People’s Republic of China 6Human Nutritioin Research Center, USDA ARS Grand Forks, Grand Forks, North Dakota Received 31 August 2012; Revised 14 January 2012; Accepted 16 January 2012 Summary: Regulators of G-protein Signaling (Rgs) Key words: Cre; loxP; FRT; conditional inactivation; Regu- proteins are the members of a multigene family of lator of G protein signaling protein GTPase-accelerating proteins (GAP) for the Galpha subunit of heterotrimeric G-proteins. Rgs proteins play critical roles in the regulation of G protein couple receptor (GPCR) signaling in normal physiology and INTRODUCTION human diseases such as cancer, heart diseases, and inflammation. Rgs12 is the largest protein of the Rgs “Regulators of G-protein signaling,” or Rgs proteins, are a protein family.
    [Show full text]
  • An Advance About the Genetic Causes of Epilepsy
    E3S Web of Conferences 271, 03068 (2021) https://doi.org/10.1051/e3sconf/202127103068 ICEPE 2021 An advance about the genetic causes of epilepsy Yu Sun1, a, *, †, Licheng Lu2, b, *, †, Lanxin Li3, c, *, †, Jingbo Wang4, d, *, † 1The School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801-3633, US 2High School Affiliated to Shanghai Jiao Tong University, Shanghai, 200441, China 3Applied Biology program, University of British Columbia, Vancouver, V6r3b1, Canada 4School of Chemical Machinery and Safety, Dalian University of Technology, Dalian, 116023, China †These authors contributed equally. Abstract: Human hereditary epilepsy has been found related to ion channel mutations in voltage-gated channels (Na+, K+, Ca2+, Cl-), ligand gated channels (GABA receptors), and G-protein coupled receptors, such as Mass1. In addition, some transmembrane proteins or receptor genes, including PRRT2 and nAChR, and glucose transporter genes, such as GLUT1 and SLC2A1, are also about the onset of epilepsy. The discovery of these genetic defects has contributed greatly to our understanding of the pathology of epilepsy. This review focuses on introducing and summarizing epilepsy-associated genes and related findings in recent decades, pointing out related mutant genes that need to be further studied in the future. 1 Introduction Epilepsy is a neurological disorder characterized by 2 Malfunction of Ion channel epileptic seizures caused by abnormal brain activity. 1 in Functional variation in voltage or ligand-gated ion 100 (50 million people) people are affected by symptoms channel mutations is a major cause of idiopathic epilepsy, of this disorder worldwide, with men, young children, and especially in rare genetic forms.
    [Show full text]
  • Ion Channels 3 1
    r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia.
    [Show full text]
  • Expression of Regulator of G Protei
    Toll-Like Receptor Signaling Alters the Expression of Regulator of G Protein Signaling Proteins in Dendritic Cells: Implications for G Protein-Coupled Receptor This information is current as Signaling of September 29, 2021. Geng-Xian Shi, Kathleen Harrison, Sang-Bae Han, Chantal Moratz and John H. Kehrl J Immunol 2004; 172:5175-5184; ; doi: 10.4049/jimmunol.172.9.5175 Downloaded from http://www.jimmunol.org/content/172/9/5175 References This article cites 49 articles, 26 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/172/9/5175.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 29, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Toll-Like Receptor Signaling Alters the Expression of Regulator of G Protein Signaling Proteins in Dendritic Cells: Implications for G Protein-Coupled Receptor Signaling Geng-Xian Shi,1 Kathleen Harrison,1 Sang-Bae Han,1 Chantal Moratz, and John H.
    [Show full text]
  • Spatial Distribution of Leading Pacemaker Sites in the Normal, Intact Rat Sinoa
    Supplementary Material Supplementary Figure 1: Spatial distribution of leading pacemaker sites in the normal, intact rat sinoatrial 5 nodes (SAN) plotted along a normalized y-axis between the superior vena cava (SVC) and inferior vena 6 cava (IVC) and a scaled x-axis in millimeters (n = 8). Colors correspond to treatment condition (black: 7 baseline, blue: 100 µM Acetylcholine (ACh), red: 500 nM Isoproterenol (ISO)). 1 Supplementary Figure 2: Spatial distribution of leading pacemaker sites before and after surgical 3 separation of the rat SAN (n = 5). Top: Intact SAN preparations with leading pacemaker sites plotted during 4 baseline conditions. Bottom: Surgically cut SAN preparations with leading pacemaker sites plotted during 5 baseline conditions (black) and exposure to pharmacological stimulation (blue: 100 µM ACh, red: 500 nM 6 ISO). 2 a &DUGLDFIoQChDQQHOV .FQM FOXVWHU &DFQDG &DFQDK *MD &DFQJ .FQLS .FQG .FQK .FQM &DFQDF &DFQE .FQM í $WSD .FQD .FQM í .FQN &DVT 5\U .FQM &DFQJ &DFQDG ,WSU 6FQD &DFQDG .FQQ &DFQDJ &DFQDG .FQD .FQT 6FQD 3OQ 6FQD +FQ *MD ,WSU 6FQE +FQ *MG .FQN .FQQ .FQN .FQD .FQE .FQQ +FQ &DFQDD &DFQE &DOP .FQM .FQD .FQN .FQG .FQN &DOP 6FQD .FQD 6FQE 6FQD 6FQD ,WSU +FQ 6FQD 5\U 6FQD 6FQE 6FQD .FQQ .FQH 6FQD &DFQE 6FQE .FQM FOXVWHU V6$1 L6$1 5$ /$ 3 b &DUGLDFReFHSWRUV $GUDF FOXVWHU $GUDD &DY &KUQE &KUP &KJD 0\O 3GHG &KUQD $GUE $GUDG &KUQE 5JV í 9LS $GUDE 7SP í 5JV 7QQF 3GHE 0\K $GUE *QDL $QN $GUDD $QN $QN &KUP $GUDE $NDS $WSE 5DPS &KUP 0\O &KUQD 6UF &KUQH $GUE &KUQD FOXVWHU V6$1 L6$1 5$ /$ 4 c 1HXURQDOPURWHLQV
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • A B C Supplementary Figure 1. Experimental Workflow And
    a c Ion channel activity Midbrain microdissection Cacna1c Cav1.2 Collected material Cacna1d Cav1.3 Cacna1g Cav3.1 SNc Hcn2 HCN2 SNr VTA Hcn4 HCN4 Scn2a1 Nav1.2 + Scn5a Nav1.5 TaqMan assays Scn8a Nav1.6 Kcna2 Kv1.2 Dissociated midbrain neurons Kcnb1 Kv2.1 Kcnd2 Kv4.2 Kcnd3 Kv4.3 Targeted reverse transcription Kcnip3 KCHIP3 and preamplification Kcnj11 Kir6.2 Abcc8 SUR1 Abcc9 SUR2B Fluorescence imaging Kcnj5 GIRK4 Kcnj6 GIRK2 GFP Kcnn3 SK3 DA metabolism & signaling Non-GFP Microfluidic quantitative PCR Th TH Slc6a3 DAT Assays Samples Slc18a2 VMAT2 Pipette harvesting Drd2 D2R Glia-specific markers Gfap GFAP Aldh1l1 FDH Calcium-ion-binding Calb1 CB Pvalb PV Other neuronal markers b 40 Slc17a6 VGLUT2 30 Gad1 GAD67 20 Gad2 GAD65 10 Chat CHAT Cell count 0 Penk ENK 16 GFP Neuronal structure Non-GFP 14 Ncam2 NCAM2 WT 12 Map2 MAP2 10 Nefm NEF3 Th (TH) 8 Neuronal activation x E Creb1 CREB 2 6 g DA neurons Fos C-FOS o 4 L (n=111) Bdnf BDNF 2 nDA neurons Housekeeping/ 0 (n=37) transcriptional factors 0 2 4 6 8 10 12 14 16 0 10 20 30 40 Hprt HGPRT Tbp TBP Log2Ex Slc6a3 (DAT) Cell count Tbx3 TBX3 Supplementary Figure 1. Experimental workflow and classification of DA and nDA neurons. a, schematic showing the workflow for the single-cell gene profiling. Left, neurons were manually collected after acute dissociation from microdissected midbrain slices containing the substantia nigra pars compacta and reticulata (SNc, SNr) and part of the ventral tegmental area (VTA) obtained from TH-GFP mice.
    [Show full text]